Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Yichang Hec Changjiang Pharm
1558Current price
8.7 HKD
0 HKD (0.00%)
Last closed
8.85 HKD
Company
cj.hec.cn
ISIN
CNE1000023R6
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
8 182 771 618 HKD
Yield for 12 month
+24.11 %
1Y
3Y
5Y
10Y
15Y
1558
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. The company's products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. Address: No. 38, Binjiang Road, Yichang, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
120.57 HKDP/E ratio
4.2732Dividend Yield
–Current Year
+6 890 789 857 HKD
Last Year
+4 099 663 008 HKD
Current Quarter
+3 512 949 377 HKD
Last Quarter
–
Current Year
+5 458 001 121 HKD
Last Year
+3 115 645 885 HKD
Current Quarter
+2 806 785 686 HKD
Last Quarter
–
Key Figures 1558
1 year
3 years
5 years
10 years
EBITDA
2 519 483 271 HKD
Operating Margin TTM
PE Ratio
4.2732
Return On Assets TTM
10.3 %
PEG Ratio
–
Return On Equity TTM
19.25 %
Wall Street Target Price
120.57 HKD
Revenue TTM
5 534 498 943 HKD
Book Value
9.84 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-23.5 %
Dividend Yield
–
Gross Profit TTM
483 188 626 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
-33.5 %
Profit Margin
29.74 %
Dividend Analytics 1558
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
44 %Dividend History 1558
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
29.09.2020
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
09.06.2020
Dividend Date
–
Stock Valuation 1558
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
4.2732
Forward PE
–
Enterprise Value Revenue
1.4183
Price Sales TTM
1.4785
Enterprise Value EBITDA
4.3093
Price Book MRQ
0.8724
Financials 1558
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1558
For 52 weeks
6.13 HKD
13.29 HKD
50 Day MA
9.34 HKD
Shares Short Prior Month
–
200 Day MA
9.95 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart